Literature DB >> 8173917

Should general surgeons treat gastric carcinoma? An audit of practice and results, 1980-1985.

P McCulloch1.   

Abstract

An audit of treatment of gastric carcinoma was conducted in a major general hospital unit in the UK over a 5-year period. In all, 206 patients (114 men, 92 women) with a mean age of 68 years were treated. Operation was performed in 150 patients; 87 underwent gastrectomy with 31 procedures appearing potentially curative. Most tumours were advanced at diagnosis: 92 were stage IV and 34 stage IIIB, with 42 tumours at earlier stages. After the 87 gastrectomies anastomotic leakage occurred in 16 patients (18 per cent) and there were 14 deaths (16 per cent). The rates of resectability, inadequate resection, anastomotic leakage and postoperative mortality varied considerably between surgeons. The 5-year survival rate was 5 per cent overall, 11 per cent after gastrectomy and 32 per cent following curative resection. The results of treatment of gastric cancer by general surgeons are poor and show marked variation between operators. The declining incidence of the disease makes prospective audit difficult. Treatment by fewer surgeons specializing in this area might improve the outcome.

Entities:  

Mesh:

Year:  1994        PMID: 8173917     DOI: 10.1002/bjs.1800810332

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

Review 1.  Stomach cancer.

Authors:  Charles Bailey
Journal:  BMJ Clin Evid       Date:  2011-03-28

Review 2.  Stomach cancer.

Authors:  Charles Bailey
Journal:  BMJ Clin Evid       Date:  2008-09-03

3.  Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer? A result based on a hospital population of two decades as taking D2 surgery for reference.

Authors:  Hao Zhang; Caigang Liu; Di Wu; Yi Meng; Ruonan Song; Ping Lu; Shubao Wang
Journal:  BMC Cancer       Date:  2010-06-20       Impact factor: 4.430

4.  Workload and resource implications of upper gastrointestinal cancer surgical centralisation in South East Wales.

Authors:  M A Morgan; M Goodson; X Escofet; G W B Clark; W G Lewis
Journal:  Ann R Coll Surg Engl       Date:  2008-09       Impact factor: 1.891

5.  The influence of training level and surgical experience on survival in colorectal cancer.

Authors:  Marja Hilska; Peter J Roberts; Jyrki Kössi; Hannu Paajanen; Yrjö Collan; Matti Laato
Journal:  Langenbecks Arch Surg       Date:  2004-10-02       Impact factor: 3.445

6.  Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy.

Authors:  Juan J Grau; Ramon Palmero; Maribel Marmol; Jose Domingo-Domenech; Mariano Monzo; Jose Fuster; Oscar Vidal; Constantino Fondevila; Juan C Garcia-Valdecasas
Journal:  World J Surg Oncol       Date:  2006-08-11       Impact factor: 2.754

7.  Value of individual surgeon performance metrics as quality assurance measures in oesophagogastric cancer surgery.

Authors:  A G M T Powell; J Wheat; N Patel; D Chan; A Foliaki; S A Roberts; W G Lewis
Journal:  BJS Open       Date:  2019-11-04

8.  Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.

Authors:  A Bamias; D Cunningham; V Nicolson; A Norman; M Hill; M Nicolson; M O'Brien; A Webb; A Hill
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.